Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Nu Skin Enterprises, Inc. (NYSE: NUS – Get Rating) by 19.9% in Q1, reports Holdings Channel. The company held 6,577 shares of the company after purchasing an additional 1,091 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Nu Skin Enterprises were worth $315,000 when it last filed with the SEC.
Several other institutional investors and hedge funds also changed their stakes in the company. Millennium Management LLC increased its position in Nu Skin Enterprises by 1,050.2% during the 4th quarter. Millennium Management LLC now owns 703,938 shares of the company worth $35,725,000 after acquiring an additional 642,738 shares in the last quarter. Cooper Creek Partners Management LLC acquired a new position in Nu Skin Enterprises during the 4th quarter at a value of $23,609,000. ProShare Advisors LLC increased its position in Nu Skin Enterprises by 30.8% during the 4th quarter. ProShare Advisors LLC now owns 736,731 shares of the company worth $37,389,000 after acquiring an additional 173,643 shares in the last quarter. Mirabella Financial Services LLP acquired a new position in Nu Skin Enterprises during the 4th quarter for a value of $6,587,000. Finally, JPMorgan Chase & Co. increased its equity stake in Nu Skin Enterprises by 62.9% during the 4th quarter. JPMorgan Chase & Co. now owns 295,510 shares of the company worth $14,997,000 after purchasing an additional 114,061 shares during the period. Institutional investors and hedge funds hold 93.79% of the company’s shares.
Insiders place their bets
In other Nu Skin Enterprises news, Chairman Steven Lund sold 900 shares of the company in a trade dated Friday, June 17. The shares were sold at an average price of $45.01, for a total transaction of $40,509.00. Following the sale, the president now directly owns 26,600 shares of the company, valued at $1,197,266. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available via this link. In other Nu Skin Enterprises news, Chairman Steven Lund sold 900 shares of the company in a trade dated Friday, June 17. The shares were sold at an average price of $45.01, for a total transaction of $40,509.00. Following the sale, the president now directly owns 26,600 shares of the company, valued at $1,197,266. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available via this link. Additionally, CEO Ryan S. Napierski sold 25,000 shares of the company in a trade dated Wednesday, May 25. The stock was sold at an average price of $44.91, for a total transaction of $1,122,750.00. As a result of the sale, the CEO now directly owns 122,683 shares of the company, valued at $5,509,693.53. The disclosure of this sale can be found here. In the past ninety days, insiders have sold 148,143 shares of the company valued at $6,652,437. 2.80% of the shares are currently held by insiders.
Analysts set new price targets
Several research analysts have recently released reports on the stock. StockNews.com upgraded Nu Skin Enterprises shares from a “hold” rating to a “buy” rating in a Wednesday, June 22 report. TheStreet upgraded Nu Skin Enterprises shares from a “c+” rating to a “b” rating in a Tuesday, June 7 report. Two equity research analysts gave the stock a hold rating and two gave the company a buy rating. Based on data from MarketBeat.com, Nu Skin Enterprises currently has an average rating of “Moderate Buy” and a consensus target price of $61.50.
Nu Skin Enterprises Stock Performance
NYSE NUS opened at $41.66 on Friday. The stock has a market capitalization of $2.09 billion, a P/E ratio of 15.43 and a beta of 1.21. The company’s 50-day simple moving average is $44.76 and its 200-day simple moving average is $47.52. Nu Skin Enterprises, Inc. has a 12-month low of $39.40 and a 12-month high of $56.76. The company has a quick ratio of 0.95, a current ratio of 1.72 and a debt ratio of 0.28.
Nu Skin Enterprises (NYSE:NUS – Get Rating) last released its results on Wednesday, May 4. The company reported earnings per share of $0.76 for the quarter, beating consensus analyst estimates of $0.73 by $0.03. The company posted revenue of $604.90 million for the quarter, compared to $579.70 million expected by analysts. Nu Skin Enterprises achieved a net margin of 5.28% and a return on equity of 22.05%. The company’s revenue for the quarter was down 10.7% year over year. In the same quarter a year earlier, the company posted earnings per share of $0.91. As a group, research analysts expect Nu Skin Enterprises, Inc. to post earnings per share of 3.64 for the current fiscal year.
Nu Skin Enterprises Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 8. Shareholders of record on Friday, May 27 received a dividend of $0.385 per share. The ex-dividend date was Thursday, May 26. This represents an annualized dividend of $1.54 and a yield of 3.70%. Nu Skin Enterprises’ dividend payout ratio is 57.04%.
Nu Skin Enterprises Company Profile
(Get an evaluation)
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems and ageLOC LumiSpa skin cleansing and treatment devices; and ageLOC Boost, plus a range of other cosmetic and personal care products.
Want to see which other hedge funds hold NUS? Visit HoldingsChannel.com for the latest 13F filings and insider trading for Nu Skin Enterprises, Inc. (NYSE: NUS – Get Rating).
Receive daily news and reviews for Nu Skin Enterprises – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s free daily email newsletter.